Pharmacyte Biotech, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
PharmaCyte Biotech, Inc. calls a special meeting to approve a significant share issuance for recent financing and an increase in its equity incentive plan.
NASDAQ
PharmaCyte Biotech, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
PharmaCyte Biotech will hold its annual stockholder meeting virtually on April 24, 2025, to elect directors, ratify the appointment of its accounting firm, and conduct an advisory vote on executive compensation.
NASDAQ
PharmaCyte Biotech will hold its annual stockholder meeting virtually on April 29, 2024, to elect directors and ratify the appointment of its accounting firm.